Long BIIB

NASDAQ:BIIB1D

Biogen Inc.NASDAQ

Description

⋅ Jan 8, 2021 10:45 PM

BIIB Daily Chart , Not a High Quality Trade!

Trade closed: target reached

⋅ Jan 15, 2021 9:26 PM

Boooom

Trend Analysis

Comments

Soartrader1

⋅ Jan 9, 2021 5:28 AM

It will be a high quality trade if BIIB reruns their clinical trial on Aducanumab @10mg/kg, factors out the APO-E carriers and can show statistical improvement in cognition without adverse side effects. Will know by March if they hold an ace